Pharming Group N.V. (FRA:PHGN)
Germany flag Germany · Delayed Price · Currency is EUR
1.440
-0.085 (-5.57%)
At close: Nov 28, 2025

Revenue by Product

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Recombinant Human C1 Esterase Inhibitor
226.91M
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human C1 Esterase Inhibitor Growth
15.98%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
United States
221.17M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
16.17%
Log In
Log In
Log In
Log In
Upgrade
Europe and Rest of World
5.74M
Log In
Log In
Log In
Log In
Upgrade
Europe
-
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
-
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
-
Log In
Log In
Log In
Log In
Upgrade